With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
A novel model to predict hearing loss after radiation +/- cisplatin for head and neck cancer based a pre-treatment data has been validated on an external cohort of 105 patients. | Deutsch, JAMA Otolaryngol Head Neck Surg 2020